SELECT: high-precision genome editing strategy via integration of CRISPR–Cas and DNA damage response for cross-species applications
Nucleic Acids Research · 20.06.2025 · 53 (12)
DOI: 10.1093/nar/gkaf595 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 26.06.2025. Verfasst von Xiaohang Liu und 18 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian, 116024, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing, DNA Damage. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Xingliao Talent Plan.
Abstract (Originalsprache)
CRISPR-based methods enable genome modifications for diverse applications but often face challenges, such as inconsistent efficiencies, reduced performance in iterative modifications, and difficulties generating high-quality datasets for high-throughput genome engineering. Here, we present SELECT (SOS Enhanced programmabLE CRISPR-Cas ediTing), a novel strategy integrating the CRISPR–Cas system with the DNA damage response. By employing designed and optimized double-strand break induced promoters that are activated upon genome editing, SELECT enables a counter-selection process to eliminate unedited cells, ensuring high-fidelity editing. This approach achieves up to 100% efficiency for point mutations, iterative knockouts, and insertions. In high-throughput library editing, SELECT achieved up to 94.2% efficiency and preserved higher library diversity compared with conventional methods. Application of SELECT in flaviolin biosynthesis resulted in a 3.97-fold increase in production. Furthermore, integration with machine learning tools allowed rapid mapping of genotype–phenotype relationships. SELECT provides a versatile platform for precision genome engineering in Escherichia coli and Saccharomyces cerevisiae.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian, 116024, China.
- Central Hospital of Dalian University of Technology, Dalian, 116024, China.
- NingBo Institute of Dalian University of Technology, Ningbo, 315016, China.
ORCID-Profile: Rongming Liu
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Xingliao Talent Plan
- Science and Technology Innovation Foundation of Dalian
- Natural Science Foundation of Liaoning Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Liu, X., Tan, H., Wang, J., Cao, Y., Li, P., Fan, X., Wang, Q., Zhang, H., Zhang, J., Yang, T., Zhao, G., Zhang, X., Duan, X., Zi, L., Liu, L., Ma, L., Chen, Z., Liang, L., & Liu, R. (2025). SELECT: high-precision genome editing strategy via integration of CRISPR–Cas and DNA damage response for cross-species applications. Nucleic Acids Research, 53(12). https://doi.org/10.1093/nar/gkaf595
Vancouver
Liu X, Tan H, Wang J, Cao Y, Li P, Fan X, et al. SELECT: high-precision genome editing strategy via integration of CRISPR–Cas and DNA damage response for cross-species applications. Nucleic Acids Research. 2025;53(12). doi:10.1093/nar/gkaf595
BibTeX
@article{Liu2025,
author = {Liu, Xiaohang and Tan, Huiping and Wang, Junyan and Cao, Yaming and Li, Pengpai and Fan, Xiangrui and Wang, Qingqing and Zhang, Haonan and Zhang, Jingjing and Yang, Tianxiang and Zhao, Guofu and Zhang, Xiaohui and Duan, Xiaoyan and Zi, Lihan and Liu, Lin and Ma, Liming and Chen, Zhiying and Liang, Liya and Liu, Rongming},
title = {SELECT: high-precision genome editing strategy via integration of CRISPR–Cas and DNA damage response for cross-species applications},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {12},
doi = {10.1093/nar/gkaf595}
}
EUVIMED